Clinical Studies: 2008 Start Date

Atopic Dermatitis
Sponsor: Taro Pharmaceuticals USA, Inc.
A Randomized, Double-blind, Placebo-Controlled, Parallel Design, Multiple-Site Clinical Study to Evaluate the Bioequivalence of Two XXXXX Formulations in Patients with Moderate to Severe Atopic Dermatitis
November 2008 to 2009

Psoriasis
Sponsor: Abbott Laboratories
A 10-Year, Post-Marketing, Observational, Registry of XXXXX in Adult Patients with Chronic Plaque Psoriasis
November 2008 to Present

Hypertension/Diabetes Mellitus
Sponsor: Novartis
An 8-Week Randomized, Double-blind, Parallel-Group, Multicenter, Active-Controlled Dose Escalation Study to Evaluate the Efficacy and Safety of XXXXX Compared to XXXXX in Patients with Stage 2 Systolic Hypertension and Diabetes Mellitus
November 2008 to Present

Psoriasis
Sponsor: Celgene Corporation
A Phase 2B, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-Ranging, Efficacy and Safety Study of XXXXX in Subjects with Moderate to Severe Plaque-Type Psoriasis
October 2008 to January 2010

Acne
Sponsor: Stiefel Laboratories
A Phase 3 Multicenter, Randomized, Double-blind, Active and Vehicle-Controlled Study of the Safety and Efficacy of XXXXX Versus XXXXX Versus XXXXX Versus Vehicle Gel in Subjects with Acne Vulgaris
October 2008 to 2009

Psoriasis
Sponsor: Novo Nordisk
A Randomized, Double-blind, Placebo-Controlled, Single and Multiple dose, Dose-Escalation Trial of XXXXX in Psoriatic Subjects, Followed by an Expansion Phase.
October 2008 to Present

Psoriasis
Sponsor: Genzyme Corporation
A Multicenter, Double-blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of XXXXX in the Treatment of Subjects with Moderate to Severe Chronic Plaque Psoriasis
August 2008 to 2009

Hereditary Angioedema
Sponsor: Pharming
A Randomized, Placebo-controlled, Double-blind Phase II Study of the Safety and Efficacy of XXXXX for the Treatment of Acute Attacks in Patients with Hereditary Angioedema
July 2008 to January 2010

Psoriasis
Sponsor: Centocor, Inc.
A Multicenter, Open Registry of Patients with Psoriasis Who Are Candidates for Systemic Therapy Including Biologics
May 2008 to Present

Psoriasis
Sponsor: Abbott Laboratories
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of XXXXX to Etanercept and Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis.
March 2008 to 2009

Psoriasis
Sponsor: Abbott Laboratories
A Phase 3, Multicenter, Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects who Completed a Preceding Psoriasis Study With XXXXX
March 2008 to Present

Psoriasis
Sponsor: Genentech, Inc.
A Phase IV Randomized, Double-Blind, Placebo Controlled Study To Evaluate the Safety and Efficacy of XXXXX in Adult Patients with Moderate to Severe Plaque Psoriasis with Involvement of the Scalp.
March 2008 to 2009

Chronic Obstructive Pulmonary Disease
Sponsor: Novartis
A 12-week Treatment, Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of XXXXX in Patients with Chronic Obstructive Pulmonary Disease
February 2008 to August 2009

Clinical Studies